EFSA seeks experts for scientific panels
The European Food Safety Authority (EFSA) said it is seeking independent experts to serve on a raft of its scientific committees and panels.
Archives for April 3, 2011
Vitamin D may or may not have heart health benefits
Low levels of vitamin D are associated with reductions in blood vessel functioning, but this may not translate into an effect on cardiovascular disease incidence, according to the results from two new studies.
Naturex set for “one or two” acquisitions in 2011: President
Naturex will expand again in 2011 with several “€5-20m” targets, 1.5 years after completing the €110m integration of Spanish supplier Natraceutical that made the French botanical extracts supplier the biggest in the world.
Denomega launches salmon oil for supplements
Denomega Pure Health is launching a salmon oil for use in liquid dietary supplements, made using a cold-press technique from farmed Norwegian salmon and pitched at the premium market.
‘Special’ coffee may protect against DNA damage: Study
Three to four cups of a ‘special’ coffee rich in green coffee bean compounds and roast products may protect oxidative damage to DNA and help reduce body fat, say new results published today.
NutraCea: Defatted rice bran could provide key to lower-fat nuggets
A raft of higher-value products targeting humans rather than animals - from an ultra-potent antioxidant-rich rice bran oil to rice lecithin and food grade defatted rice bran – will help NutraCea puts its troubled past behind it in 2011/12, bosses have...
BASF hikes carotenoid prices 12%
BASF has upped the price of its food and feed nature-identical carotenoid formulations suite by around 12% due to increased, “energy and raw material prices, higher logistics costs and negative exchange rate effects.”
Danisco forms pine-sourced phytosterol partnership
Scandinavian ingredients giant Danisco has signed a “long term” deal to market globally the free and esterified phytosterol offerings of US firm Arboris.
Breaking news
Pfizer to sell Capsugel for $2.4 billion
It's been on the cards since the fall, and now it's official: Pfizer has agreed to sell hard-capsule manufacturer Capsugel for $2.375 billion in cash to an affiliate of Kohlberg Kravis Roberts & Co L.P. (KKR).
GNC goes public (third time lucky)
The parent company of General Nutrition Centers (GNC) Inc has begun trading on the New York Stock Exchange, joining rival Vitamin Shoppe, which went public in late 2009.